Background: Alu is one of the non-autonomous element retrotransposons, constituting nearly 11% of the human DNA. Methylation changes of the Alu element can cause genomic instability, a hallmark of cancer development, ultimately leading to the development of cancer. Epigenetic factors may induce the aberrant methylation of Alu and also oxidative stress. However, current knowledge of Alu methylation and oxidative stress is limited. There are few studies that have evaluated Alu methylation and oxidative stress on musculoskeletal tumor progression. Therefore, the present study evaluated the status of Alu methylation in musculoskeletal (MS) tumor, adjacent tissues, and blood leukocytes from MS tumor subjects, as well as unaffected participants. Moreover, we also investigated the oxidative stress status in MS tumor subjects and the control participants and determined the correlation between Alu methylation in MS tumors and that in blood leukocytes.
Methods: Musculoskeletal tumors from musculoskeletal tumor patients ( = 40) were compared to adjacent tissues ( = 40). The blood leukocytes from musculoskeletal tumor patients were compared to the blood leukocytes from controls ( = 107). Alu methylation status was analyzed using quantitative combined bisulfite restriction analysis (COBRA). In addition, 8-hydroxy 2'-deoxyguanosine (8-OHdG) values were determined using enzyme-linked immunosorbent assay.
Results: Alu methylation values in MS tumors were statistically significantly higher than those in adjacent tissues ( = 0.035). Similarly, Alu methylation statuses in the blood leukocytes of MS tumor subjects were statistically greater than those of control participants ( < 0.001). Moreover, there was a positive association between Alu methylation levels in MS tumors and blood leukocytes ( = 0.765, < 0.001). In addition, the highest tertile was significantly associated with the risk of MS tumors (OR = 14.17, 95% CI [5.08-39.51]; < 0.001). The 8-OHdG values in MS tumors were statistically higher than in adjacent tissues ( < 0.001) and circulating 8-OHdG levels were substantially greater in MS tumor subjects than in the control participants ( < 0.001).
Discussion: These findings suggest that Alu methylation in blood leukocytes and plasma 8-OHdG might represent non-invasive biomarkers to help diagnose MS tumors. Therefore, Alu hypermethylation and high oxidative stress might be involved in the pathogenesis of the musculoskeletal tumors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098941 | PMC |
| http://dx.doi.org/10.7717/peerj.5492 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple-negative breast cancer.
Int J Cancer
December 2024
Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, One Medical Center Drive, Lebanon, New Hampshire, USA.
Article Synopsis
- Triple-negative breast cancer (TNBC) is a highly aggressive subtype with varied characteristics, limited treatment choices, and poor clinical outcomes, particularly when associated with homologous recombination deficiency (HRD).
- The study analyzed TNBC tumors from two groups (n=32 and n=58), revealing significant differences in genome-wide copy number and methylation alterations linked to HRD, including lower methylation in specific genomic regions.
- Findings indicate that HRD in TNBC is associated with key biological pathways, and using machine learning can aid in classifying tumors based on HRD and methylation patterns, offering potential for improved treatment strategies.
Acteoside alleviates salsolinol-induced Parkinson's disease by inhibiting ferroptosis via activating Nrf2/SLC7A11/GPX4 pathway.
Exp Neurol
December 2024
Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, China. Electronic address:
Article Synopsis
- Salsolinol (SAL) is a neurotoxin linked to the development of Parkinson's disease (PD) by causing damage to dopaminergic neurons, and its mechanisms of toxicity involve inducing ferroptosis.
- The study utilized RNA sequencing and biochemical analysis to show that SAL decreases the levels of proteins SLC7A11 and GPX4, leading to ferroptosis in neuroblastoma cells, which can be reversed by ferroptosis inhibitors.
- Acteoside, a neuroprotective compound, counteracts SAL-induced neurotoxicity by enhancing SLC7A11 and GPX4 levels through activation of the Nrf2 pathway, suggesting a potential therapeutic strategy for PD by targeting ferroptosis.
Altered Methylation Levels in LINE-1 in Dental Pulp Stem Cell-Derived Osteoblasts.
Int Dent J
October 2024
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand. Electronic address:
Objectives: Long interspersed nuclear element-1 (LINE-1) and Alu elements are major targets of methylation, an epigenetic mechanism that is associated with several biological processes. Alterations of methylation of LINE-1 and Alu have been reported in cancers, diseases, and ageing. However, these alterations have not been studied in osteogenic differentiation of dental pulp stem cells (DPSCs), which are a promising source of tissue regeneration.
View Article and Find Full Text PDFAlterations of senescence-associated markers in patients with non-syndromic cleft lip and palate.
Sci Rep
September 2024
Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
Article Synopsis
- Non-syndromic cleft lip with or without palate (NSCL/P) is a common birth defect, potentially influenced by abnormal DNA methylation in pregnant mothers.
- The study involved 39 NSCL/P patients and 33 mothers, analyzing Alu methylation and cellular aging markers in blood and tissue samples.
- Findings showed specific patterns of Alu methylation changes in patients with cleft lip and palate, indicating the mother's methylation status may contribute to the severity of the child's cleft condition.
Retrotransposons and Diabetes Mellitus.
Epigenomes
September 2024
Department of Endocrinology, University of Ioannina, 45110 Ioannina, Greece.
Retrotransposons are invasive genetic elements, which replicate by copying and pasting themselves throughout the genome in a process called retrotransposition. The most abundant retrotransposons by number in the human genome are Alu and LINE-1 elements, which comprise approximately 40% of the human genome. The ability of retrotransposons to expand and colonize eukaryotic genomes has rendered them evolutionarily successful and is responsible for creating genetic alterations leading to significant impacts on their hosts.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!